Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vaxart Inc
(NQ:
VXRT
)
0.6855
-0.0370 (-5.12%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vaxart Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Oral Vaccine Focused Penny Stock Vaxart Is 'Uniquely Positioned', Analyst Sees Almost 83% Upside
August 15, 2024
Oppenheimer initiates Vaxart coverage with an Outperform rating and $4 price target, citing a bullish outlook on its oral vaccines for COVID-19 and norovirus.
Via
Benzinga
Exposures
COVID-19
VXRT Stock Earnings: Vaxart Misses EPS, Beats Revenue for Q2 2024
August 08, 2024
VXRT stock results show that Vaxart missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
$1M Bet On This Penny Stock? Check Out These 4 Stocks Under $2 Insiders Are Aggressively Buying
June 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 18, 2024
Via
Benzinga
Recap: Vaxart Q4 Earnings
March 14, 2024
Via
Benzinga
Vaxart's Earnings: A Preview
March 13, 2024
Via
Benzinga
What's Going On With Vaxart Stock Today?
January 17, 2024
Vaxart shares are trading higher by around 8% Wednesday afternoon. The company recently secured a contract from the U.S. Government via the Department of Health and Human Services.
Via
Benzinga
Vaxart's Earnings Outlook
November 01, 2023
Via
Benzinga
Vaxart Stock Is Moving Higher After The Bell: What's Going On?
June 17, 2024
Vaxart, a clinical-stage biotechnology company developing a range of oral recombinant vaccines, announced Monday that proceeds from a recent offering combined with reimbursements under its Project...
Via
Benzinga
Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering
June 14, 2024
Vaxart (VXRT) shares surged 23% in premarket session after receiving a $453 million project award from BARDA to conduct a COVID-19 vaccine study.
Via
Benzinga
Exposures
COVID-19
Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
June 14, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 14, 2024
Pre-market stock movers are worth checking out on Friday as we dive into all of the biggest news moving shares this morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
June 13, 2024
Via
Benzinga
Palo Alto Networks Shares Drop After Q3 Results, In-Line Guidance: The Details
May 20, 2024
Palo Alto Networks reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.25 by 5.6%. Quarterly sales clocked in at $1.985 billion which beat the analyst...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 14, 2024
Via
Benzinga
VXRT Stock Earnings: Vaxart Meets EPS, Beats Revenue for Q1 2024
May 13, 2024
VXRT stock results show that Vaxart met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
May 13, 2024
Via
Benzinga
Vaxart Stock Climbs After Blockbuster Q1 Revenue
May 13, 2024
Vaxart reported quarterly losses of 14 cents per share, inline with the analyst consensus estimate. Quarterly sales clocked in at $2.181 million, beating the analyst consensus estimate of $800,000 by...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
May 10, 2024
Via
Benzinga
Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
April 09, 2024
These seven companies were the top 2020 stocks. After their glory years have faded, they are looking to turn their fortunes around.
Via
InvestorPlace
VXRT Stock Earnings: Vaxart Beats EPS, Beats Revenue for Q4 2023
March 14, 2024
VXRT stock results show that Vaxart beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 31, 2024
Via
Benzinga
Earnings Scheduled For March 14, 2024
March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
Via
Benzinga
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 31, 2024
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 16, 2024
Via
Benzinga
What's Going On With Vaxart (VXRT) Stock?
January 16, 2024
Vaxart shares are trading higher by 17.8% Tuesday morning amid multiple news items. The company recently secured a contract from the U.S. Government via the Department of Health and Human Services.
Via
Benzinga
Earnings Scheduled For November 2, 2023
November 02, 2023
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
Via
Benzinga
Why Biophytis Shares Are Trading Higher By Over 12%: Here Are 20 Stocks Moving Premarket
October 30, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
October 30, 2023
It's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage!
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.